Opinion: Tax, immigration, social security, payroll, and global mobility data can no longer be managed in isolation when employees or executives work across borders.
The Trump administration’s push to bring US drug spending down is a powerful incentive for pharmaceutical companies to boost prices and reduce access elsewhere in the world, a study found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results